Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Direct and Indirect Benefits of Influenza Vaccination
NCT00981513Phase 4Completed
- Sponsor
- The University of Hong Kong
- Start
- Sep 2009
- Primary completion
- Nov 2010
- Modality
- Live Attenuated Vaccines
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of live attenuated influenza vaccine and influenza A (H1N1) 2009 monovalent vaccine live in influenza (2 arms), sponsored by The University of Hong Kong. Primary endpoints: Clinical influenza by self-reported symptoms at 1 year and Influenza virus infection confirmed by RT-PCR at 1 year. Started Sep 2009; status: completed.
02
Drugs
live attenuated influenza vaccineinfluenza A (H1N1) 2009 monovalent vaccine live
03
Conditions
influenza
Beyond the preview
Go deeper on NCT00981513.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00981513.